About Fundaciò ACE- Institut Català de Neurociències Aplicades
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Fundaciò ACE- Institut Català de Neurociències Aplicades
During the past decade, Fundaciò ACE- Institut Català de Neurociències Aplicades conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fundaciò ACE- Institut Català de Neurociències Aplicades" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Pfizer" with 3 trials
sponsored, "Bellus Health Inc" with 1 trials sponsored, "Fundació ACE Institut Català de Neurociències Aplicades" with 1 trials sponsored and "TauRx Therapeutics Ltd"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fundaciò ACE- Institut Català de Neurociències Aplicades"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "Julius Clinical" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Fundaciò ACE- Institut Català de Neurociències Aplicades
According to Clinical.Site data, the most researched conditions in "Fundaciò ACE- Institut Català de Neurociències Aplicades" are
"Alzheimer's Disease" (4 trials), "Alzheimer Disease" (3 trials), "Alzheimer´s Disease" (1 trials), "Behavioral Variant Frontotemporal Dementia (bvFTD)" (1 trials) and "Mild Cognitive Impairment (MCI)" (1 trials). Many other conditions were trialed in "Fundaciò ACE- Institut Català de Neurociències Aplicades" in a lesser frequency.
Clinical Trials Intervention Types at Fundaciò ACE- Institut Català de Neurociències Aplicades
Most popular intervention types in "Fundaciò ACE- Institut Català de Neurociències Aplicades" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Lanabecestat" (3 trials), "bapineuzumab" (2 trials), "placebo" (2 trials) and "3APS" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fundaciò ACE- Institut Català de Neurociències Aplicades
The vast majority of trials in "Fundaciò ACE- Institut Català de Neurociències Aplicades" are
10 trials for "All" genders.
Clinical Trials Status at Fundaciò ACE- Institut Català de Neurociències Aplicades
Currently, there are NaN active trials in "Fundaciò ACE- Institut Català de Neurociències Aplicades".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Fundaciò ACE- Institut Català de Neurociències Aplicades,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Fundaciò ACE- Institut Català de Neurociències Aplicades, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Fundaciò ACE- Institut Català de Neurociències Aplicades
Fundaciò ACE- Institut Català de Neurociències Aplicades has several departments that took part in Clinical trials: "Fundación ACE; Servicio de Neurología" - 6 trials